Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress

Hypertension

Volumn 51, Issue 5, 2008, Pages 1358-1365

  Shen, Bo ^a   Hagiwara, Makoto ^a   Yao, Yu Yu ^a   Chao, Lee ^a   Chao, Julie ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Dahl salt sensitive rat; Fibrosis; Inflammation; Kallistatin; Reactive oxygen species

Indexed keywords

CARRIER PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; INTERCELLULAR ADHESION MOLECULE 1; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 14; NITRIC OXIDE SYNTHASE; PROTEIN KALLISTATIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL INFILTRATION; DAHL SALT SENSITIVE RAT; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE TARGETING; GLOMERULOSCLEROSIS; IN VIVO STUDY; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; LIPID PEROXIDATION; MALE; NEPHRITIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEINURIA; RAT; SALT INTAKE; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; CELLS, CULTURED; COLLAGEN; DISEASE MODELS, ANIMAL; FIBROSIS; INFLAMMATION; KIDNEY DISEASES; KIDNEY TUBULES, PROXIMAL; MALE; MESANGIAL CELLS; NITRIC OXIDE SYNTHASE TYPE III; NITROGEN OXIDES; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, INBRED DAHL; REACTIVE OXYGEN SPECIES; SERPINS; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 42349108155     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.108514     Document Type: Article

References (36)

1. Chao J, Tillman DM, Wang MY, Margolius HS, Chao L. Identification of a new tissue-kallikrein-binding protein. Biochem J. 1986;239:325-331.
2. Chao J, Chai KX, Chen LM, Xiong W, Chao S, Woodley-Miller C, Wang LX, Lu HS, Chao L. Tissue kallikrein-binding protein is a serpin. I. Purification, characterization, and distribution in normotensive and spontaneously hypertensive rats. J Biol Chem. 1990;265:16394-16401.
3. Chen LM, Song Q, Chao L, Chao J. Cellular localization of tissue kallikrein and kallistatin mRNAs in human kidney. Kidney Int. 1995;48:690-697.
4. Chao J, Schmaier A, Chen LM, Yang Z, Chao L. Kallistatin, a novel human tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease. J Lab Clin Med. 1996;127:612-620.
5. Wolf WC, Harley RA, Sluce D, Chao L, Chao J. Localization and expression of tissue kallikrein and kallistatin in human blood vessels. J Histochem Cytochem. 1999;47:221-228.
6. Wolf WC, Harley RA, Sluce D, Chao L, Chao J. Cellular localization of kallistatin and tissue kallikrein in human pancreas and salivary glands. Histochem Cell Biol. 1998;110:477-484.
7. Chao J, Chen LM, Chai KX, Chao L. Expression of kallikrein-bonding protein and α1-antitrypsin genes in response to sex hormones, growth, inflammation and hypertension. Agents Actions Suppl. 1992;174-181.
8. Chen LM, Chao L, Chao J. Beneficial effects of kallikrein-binding protein in transgenic mice during endotoxic shock. Life Sci. 1997;60:1431-1435.
9. Wang CR, Chen SY, Wu CL, Liu MF, Jin YT, Chao L, Chao J. Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation. Arthritis Rheum. 2005;52:1319-1324.
10. Chao J, Yin H, Yao YY, Shen B, Smith RS, Chao L. Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation. Hum Gene Ther. 2006;17:1201-1213.
11. Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ. Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol. 2004;286:F606-F616.
12. Karlsen FM, Andersen CB, Leyssac PP, Holstein-Rathlou NH. Dynamic autoregulation and renal injury in Dahl rats. Hypertension. 1997;30:975-983.
13. Manning RD Jr, Tian N, Meng S. Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol. 2005;25:311-317.
14. Chao J, Li HJ, Yao YY, Shen B, Gao L, Bledsoe G, Chao L. Kinin infusion prevents renal inflammation, apoptosis, and fibrosis via inhibition of oxidative stress and mitogen-activated protein kinase activity. Hypertension. 2007;49:490-497.
15. Chen VC, Chao L, Chao J. Reactive-site specificity of human kallistatin toward tissue kallikrein probed by site-directed mutagenesis. Biochim Biophys Acta. 2006;1479:237-246.
16. Tang SS, Jung F, Diamant D, Brown D, Bachinsky D, Hellman P, Ingelfinger JR. Temperature-sensitive SV40 immortalized rat proximal tubule cell line has functional renin-angiotensin system. Am J Physiol. 1995;268:F435-F446.
17. Ding G, Zhang A, Huang S, Pan X, Chen R, Yang T. Angiotensin II induces c-Jun NH2-terminal kinase activation and proliferation of human mesangial cells via redox-sensitive transactivation of the EGF receptor. Am J Physiol Renal Physiol. 2007;293:F1889-F1897.
18. Yao K, Sato H, Ina Y, Suzuki K, Ohno T, Shirakura S. Renoprotective effects of benidipine in combination with angiotensin II type 1 receptor blocker in hypertensive Dahl rats. Hypertens Res. 2003;26:635-641.
19. Dworkin LD, Tolbert E, Recht PA, Hersch JC, Feiner H, Levin RI. Effects of amlodipine on glomerular filtration, growth, and injury in experimental hypertension. Hypertension. 1996;27:245-250.
20. Tian N, Thrasher KD, Gundy PD, Hughson MD, Manning RD Jr. Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Hypertension. 2005;45:934-939.
21. Muller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A, Theuer J, Breu V, Ganten D, Haller H, Luft FC. NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension. 2000;35:193-201.
22. Taylor NE, Glocka P, Liang M, Cowley AW Jr. NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S rats. Hypertension. 2006;47:692-698.
23. Modlinger PS, Wilcox CS, Aslam S. Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin Nephrol. 2004;24:354-365.
24. Yoshihara F, Suga S, Yasui N, Horio T, Tokudome T, Nishikimi T, Kawano Y, Kangawa K. Chronic administration of adrenomedullin attenuates the hypertension and increases renal nitric oxide synthase in Dahl salt-sensitive rats. Regul Pept. 2005;128:7-13.
25. Gloire G, Legrand-Poels S, Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol. 2006;72:1493-1505.
26. Bao W, Behm DJ, Nerurkar SS, Ao Z, Bentley R, Mirabile RC, Johns DG, Woods TN, Doe CP, Coatney RW, Ohlstein JF, Douglas SA, Willette RN, Yue TL. Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production. Cardiovasc Pharmacol. 2007;49:362-368.
27. Bonizzi G, Oiette J, Merville MP, Bours V. Cell type-specific role for reactive oxygen species in nuclear factor-κB activation by interleukin. Biochem Pharmacol. 2000;59:7-11.
28. Kuwabara N, Tamada S, Iwai T, Teramoto K, Kaneda N, Yukimura T, Nakatani T, Miura K. Attenuation of renal fibrosis by curcumin in rat obstructive nephropathy. Urology. 2006;67:440-446.
29. Messmer UK, Briner VA, Pfeilschifter J. Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells. Kidney Int. 1999;55:2322-2337.
30. Henke N, Schmidt-Ullrich R, Dechend R, Park JK, Qadri F, Wellner M, Obst M, Gross V, Dietz R, Luft FC, Scheidereit C, Muller DN. Vascular endothelial cell-specific NF-κB suppression attenuates hypertension-induced renal damage. Circ Res. 2007;101:268-276.
31. Naito T, Masaki T, Nikolic-Paterson DJ, Tanji C, Yorioka N, Kohno N. Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-β1. Am J Physiol Renal Physiol. 2004;286:F278-F287.
32. Takeda K, Matsuzawa A, Nishitoh H, Ichijo H. Roles of MAPKKK ASK1 in stress-induced cell death. Cell Struct Funct. 2003;28:23-29.
33. Cohen MP, Sharma K, Guo J, Eltayeb BO, Ziyadeh FN. The renal TGF-beta system in the db/db mouse model of diabetic nephropathy. Exp Nephrol. 1998;6:226-233.
34. Han DC, Hoffman BB, Hong SW, Guo J, Ziyadeh FN. Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice. Am J Physiol Renal Physiol. 2000;278:F628-F634.
35. Ying WZ, Sanders PW. Dietary salt enhances glomerular endothelial nitric oxide synthase through TGF-β1. Am J Physiol Renal Physiol. 1998;275:F18-F24.
36. Ying WZ, Sanders PW. The interrelationship between TGF-beta1 and nitric oxide is altered in salt-sensitive hypertension. Am J Physiol Renal Physiol. 2003;285:F902-F908.